Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news



Is theobromine responsible for cocoa’s cholesterol benefits?

By Stephen DANIELLS , 21-May-2013

Is theobromine responsible for cocoa’s cholesterol benefits?

The potential of cocoa to beneficially impact ‘good’ cholesterol levels may be linked to the theobromine content and not the flavonoids, says a new study from Unilever Research & Development Vlaardingen.

Data from a double-blind, randomized, placebo-controlled control may go some way to explaining the conflicting results seen in other cocoa studies, wrote the Unilever scientists in the American Journal of Clinical Nutrition .

“To our knowledge, this is the first study to show that a daily intake of 850 mg theobromine independently and significantly increases HDL-cholesterol concentrations by 0.16 mmol/L in healthy subjects,” wrote the researchers, led by Nicole Neufingerl.

“Together with the lack of a significant main effect of cocoa and interaction effect, this result suggests that theobromine is the major active compound in cocoa that is responsible for the beneficial HDL-cholesterol–increasing effect.”

Cocoa’s benefits

The health benefits of polyphenols from cocoa have been gathering increasing column inches in the national media. To date studies have reported potential benefits for cardiovascular health, skin health, and even brain health.

The majority of science into the potential benefits of cocoa have revolved around cardiovascular benefits of the flavanols (also known as flavan-3-ols or catechins), and particularly the monomeric flavanol (-)epicatechin.

Scientists from the University of Reading in England and Mars have also reported that cocoa may also affect gut microflora and possess prebiotic potential.

While the majority of the science has focused on the flavanols, the new study indicates that the theobromine content may be responsible for any HDL cholesterol-boosting benefits.

Study details

Neufingerl and her co-workers recruited 152 healthy men and women to participate in their 2-center, double-blind, randomized, placebo-controlled, parallel study. The participants were randomly assigned to consume a daily 200-mL drink for four weeks, which contained cocoa (150 mg theobromine and 325 mg flavonoids), pure theobromine (850 mg), cocoa and added theobromine (1000 mg theobromine and 325 mg flavonoids), or neither cocoa nor theobromine (placebo).

Results showed that there was a significant effect of the pure theobromine beverage on HDL cholesterol (+0.16 mmol/L), but no effect was observed for the cocoa-only beverage, said the researchers.

No significant interaction effect between cocoa and theobromine was observed for the combination group, they added.

In addition, the researchers also observed a significant effect of theobromine on rising apolipoprotein A-I, which is the main protein component of HDL, while LDL-cholesterol levels decreased, as did apolipoprotein B, the main apolipoprotein of LD cholesterol and responsible for the transport of cholesterol to tissues.

What’s going on?

The researchers note that the metabolism of HDL-cholesterol is complex, and several biological mechanisms have already been proposed, but their study did not examine the actual mechanism of theobromine.

“A number of epidemiologic studies, including prospective observation studies, have shown that a 1% increase in HDL cholesterol is linked to a 1–3% reduction in CVD risk, even when controlled for other risk variables,” they wrote.

“Although elevated LDL cholesterol is the most important lipid target in the prevention and treatment of CVD, and despite powerful treatment options to lower LDL-cholesterol concentrations, there remains substantial residual cardiovascular risk, which can be further reduced by targeting other blood lipids such as raising HDL cholesterol.”

Source: American Journal of Clinical Nutrition
June 2013, Volume 97, Number 6, Pages 1201-1209, doi: 10.3945/​ajcn.112.047373
“Effect of cocoa and theobromine consumption on serum HDL-cholesterol concentrations: a randomized controlled trial”
Authors: N. Neufingerl, Y.E.M.P. Zebregs, E.A.H. Schuring, E.A. Trautwein

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars